NEW YORK — A cosmetics maker is under investigation by New Jersey authorities after allegedly defrauding more than $50,000 of customers with phony products.
The U.S. Attorney’s office for the Southern District of New Jersey says the company, called BioMedix, allegedly misrepresented the quality of its products and failed to adequately secure and maintain the payment of suppliers.
BioMedix is owned by Sanofi-Pasteur.
The company has denied wrongdoing.
A complaint filed last week alleged that between October 2014 and February of this year, BioMediq allegedly paid suppliers for a variety of products that did not meet their quality standards and failed on several occasions to ensure that the product’s manufacturer had the necessary technical and manufacturing training to produce and supply the products.
BioMartix, a subsidiary of BioMediquix, is also under investigation for fraud.